作者: Diether Lambrechts , Paul Delmar , Stefan Scherer , Sanne Lysbet De Haas
DOI:
关键词:
摘要: The invention is concerned with a method of predicting patient's susceptibility to developing hypertension associated an anti-angiogenesis treatment, such as bevacizumab, by determing the genotype KDR gene and/or EGF gene. further relates pharmaceutical composition comprising angiogenesis inhibitor, for treatment patient suffering from cancer based on EGF. reducing risk therapy, in determining